1. Home
  2. SHFS vs PPBT Comparison

SHFS vs PPBT Comparison

Compare SHFS & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SHF Holdings Inc.

SHFS

SHF Holdings Inc.

HOLD

Current Price

$0.21

Market Cap

2.7M

Sector

Finance

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$1.41

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHFS
PPBT
Founded
2015
2010
Country
United States
Israel
Employees
41
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.9M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SHFS
PPBT
Price
$0.21
$1.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
744.9K
43.1K
Earning Date
04-15-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.41
52 Week High
$9.18
$5.18

Technical Indicators

Market Signals
Indicator
SHFS
PPBT
Relative Strength Index (RSI) 26.26 27.63
Support Level N/A $0.60
Resistance Level $0.26 $1.41
Average True Range (ATR) 0.02 0.12
MACD 0.01 0.04
Stochastic Oscillator 33.75 11.00

Price Performance

Historical Comparison
SHFS
PPBT

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: